Experience with monoclonal antibodies in allergic mediated disease: Seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 2, 2001, Pages S84-S88

  Casale, Thomas B ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Allergic rhinitis; Allergy; Anti IgE; Immunoglobulin; Omalizumab; Pollen

Indexed keywords

IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY; OMALIZUMAB; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; BASOPHIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BINDING; DRUG INDUCED DISEASE; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; MAST CELL; MULTICENTER STUDY; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; HUMANS; RHINITIS, ALLERGIC, SEASONAL;

EID: 0034878976     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.116433     Document Type: Article

References (22)

1. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
2. Quality of life in allergic rhinitis
3. The link between allergy and asthma
4. Therapeutic strategies for allergic disease
5. Immunotherapy for allergic rhinitis
6. Therapeutic potential of anti-IgE antibodies
7. Humanization of an antibody directed against IgE
8. Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release
9. A pharmacodynamic model describing free IgE concentrations following administration of a recombinant humanized monoclonal anti IgE antibody in humans
10. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys
11. Inhibition of allergic reactions with antibodies to IgE
12. IgE inhibition as a therapy for allergic disease
13. Anti-IgE therapy for asthma
14. Anti-IgE antibody therapy for asthma
15. Injection of anti-IgE antibodies will suppress IgE and allergic symptoms
16. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis
17. rhuMAb-E25 in the treatment of seasonal allergic rhinitis
18. rhuMAb-E25 improves quality of life in patients with seasonal allergic rhinitis (SAR)
19. Relationship between clinical efficacy of rhu-MAb-E25 (E25) and serum-free IgE in seasonal allergic rhinitis
20. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis
21. Safety of readministration of rhuMab-E25 in seasonal allergic rhinitis (SAR)
22. Nonfatal systemic reactions to subcutaneous immunotherapy: A 10-year experience